Alterity Therapeutics Limited
PRNAF
$0.01
$0.00-44.55%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.02% | -30.89% | 61.67% | 62.39% | -10.22% |
| Total Depreciation and Amortization | -19.83% | -22.22% | -11.52% | -12.81% | -1.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 203.48% | 194.23% | 34.10% | 31.57% | 137.25% |
| Change in Net Operating Assets | -66.67% | -61.57% | -67.13% | -67.74% | -223.88% |
| Cash from Operations | -27.97% | -24.06% | 62.95% | 63.64% | -85.96% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 2.93% | 2.93% | -232.43% | -232.43% | -24.45% |
| Issuance of Common Stock | 5,011.84% | 5,011.84% | 380.54% | 380.54% | -70.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3,363.13% | -3,363.13% | -318.88% | -318.88% | 87.85% |
| Cash from Financing | 6,382.92% | 6,187.59% | 368.69% | 359.90% | -71.60% |
| Foreign Exchange rate Adjustments | 5.22% | 8.03% | -158.06% | -157.04% | -1,240.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 299.42% | 293.33% | 8,639.37% | 8,474.50% | -134.60% |